期刊文献+

大面积脑梗死危险因素调查及干预探讨 被引量:8

Study on Risk Factors of Large Cerebral Infarction
在线阅读 下载PDF
导出
摘要 目的探讨大面积脑梗死的危险因素及干预措施。方法对大面积脑梗死组(40例)及对照组(191例)患者临床资料进行回顾性分析。结果两组的高血压、糖尿病、高血脂、冠心病、吸烟饮酒等卒中危险因素方面比较差异无统计学意义(P>0.05),观察组风湿性心脏病、房颤所占比例高于对照组(P<0.05)。同时发现大面积脑梗死患者发病前大多未对卒中危险因素进行有效干预治疗。结论积极干预高危因素,可防止或减少大面积脑梗死的发生。 Objective To study the risk factors of large cerebral infarction and interfere methods. Methods A retrospective investigation was conducted in 231 patients with cerebral infarction, in which 40 large cerebral infarction patients as observation group and the other 191 patients as control. Results The study indicated that the risk factors (hypertension, diabetes, hyperlipidemia, coronary heart disease, drinking and smoking) of the two groups were consistent ( P 〉 0.05 ), but there had higher rates (P 〈 0, 05 ) of rheumatic heart disease and atrial fibrillation in observation group, and most of the observation group had not take treatment of the stroke risk factors. Conclusions Actively interfering the risk factors would prevent or reduce the occurrence of large cerebral infarction,
作者 刘萍
出处 《实用全科医学》 2007年第5期417-418,共2页 Applied Journal Of General Practice
关键词 大面积脑梗死 危险因素 干预 Large cerebral infarction Risk factors Interfere
  • 相关文献

参考文献5

二级参考文献13

  • 1Mesas CE,Veloso HH,De Paola AA.Anticoagulation for atrial fibrillation:underutilization in a brazilian tertiary outpatient clinic.Clin Cardiol,2004,27 (11):592-593.
  • 2Loffe HV,Goldhaber SZ.Effectiveness and safety of long-term anticoagulation of patients≥90 years of age with atrial fibrillation.Am J Cardiol,2002,90(12):1397-1398.
  • 3Inoue H,Atarashi H,Research Group for Antiarrhythmic Drug Therapy.Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation.Am J Cardiol,2000,86 (8):852-855.
  • 4Feinberg WM,Blackshear JL,Laupacis A,et al.Prevalence,age distribution,and gender of patients with atrial fibrillation.Analysis and implications.Arch Intern Med,1995,155 (5):469-473.
  • 5York M,Agarwal A,Ezekowitz M.Physicians' attitudes and the use of oral anticoagulants:surveying the present and envisioning future.J Thromb Thrombolysis,2003,16(1-2):33-37.
  • 6Ferro JM.Atrial fibrillation and cardioembolic stroke.Minerva Cardioangiol,2004,52 (2):111-124.
  • 7Shinoda E, Yui Y, Kodama K, et al. Quantitative Coronary Anglogram Analysis: Nifedipine Retard Versus Angiotensin-Converting Enzyme Inhibitors (JMIC-B Side Arm Study) [J]. Hypertension, 2005,45:1153 - 1158.
  • 8Williams B. Recent hypertension trials : implications and controversies[ J ]. JACC, 2005,45 (6) : 813 - 827.
  • 9Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the rennin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis [ J ]. Lancet,2005,366:2026 - 2033.
  • 10Lindholm LH, Carlberg B, Samuelsson O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis[ J]. Lancet 2005 ;366:1545 - 1553.

共引文献1670

同被引文献32

引证文献8

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部